October 21, 2024 01:59 PM EDT
Pharma

Star­board takes ac­tivist stake in J&J con­sumer spin­out Ken­vue

Max Bayer

Pharma Reporter

Less than 14 months af­ter be­com­ing a stand­alone com­pa­ny, John­son & John­son’s con­sumer health­care spin­out Ken­vue is star­ing down an ac­tivist in­vestor.

The in­vestor, Star­board …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times